Julie A. Creaden is a Evanston, Illinois based nurse practitioner. Active license number of Julie A. Creaden is 277000193 in Illinois. Her current practice location is 2650 Ridge Ave, Evanston. Patients can reach her at 847-570-2013 or can fax her at 847-733-5866. Julie A. Creaden is APN-CNP and her NPI number (Unique professional ID assigned by NPPES) is 1861429680. Julie A. Creaden has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Julie A. Creaden speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1861429680
NPI Enumeration Date:
27 Jun, 2006
NPI Last Update On:
03 Feb, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Julie A. Creaden are as mentioned below.
License Number
Specialization
State
Status
277000193
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Julie A. Creaden 2650 Ridge Ave, Evanston, Illinois
Zip:
60201-1700
Phone Number:
847-570-2013
Fax Number:
847-733-5866
Patients can reach Julie A. Creaden at 2650 Ridge Ave, Evanston, Illinois or can call to book an appointment on 847-570-2013.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.